For: | Hagström H, Stål P, Stokkeland K, Bergquist A. Alcohol consumption in patients with primary sclerosing cholangitis. World J Gastroenterol 2012; 18(24): 3105-3111 [PMID: 22791946 DOI: 10.3748/wjg.v18.i24.3105] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i24/3105.htm |
Number | Citing Articles |
1 |
Anders Batman Mjelle, Anesa Mulabecirovic, Trygve Hausken, Roald Flesland Havre, Odd Helge Gilja, Mette Vesterhus. Ultrasound and Point Shear Wave Elastography in Livers of Patients with Primary Sclerosing Cholangitis. Ultrasound in Medicine & Biology 2016; 42(9): 2146 doi: 10.1016/j.ultrasmedbio.2016.04.016
|
2 |
Hannes Hagström. Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 2017; 31(5): 537 doi: 10.1016/j.bpg.2017.09.003
|
3 |
Roman Dascal, Colin Rumbolt, Julia Uhanova, Daria Surina, Grace Oketola, Byron Beardy, Gerald Y Minuk. Binge drinking does not appear to have an adverse effect on non-alcoholic fatty liver disease: Findings from a study of four First Nations communities. Canadian Liver Journal 2023; 6(1): 39 doi: 10.3138/canlivj-2022-0013
|
4 |
Friedrich Martin Wurst, Natasha Thon, Wolfgang Weinmann, Michel Yegles, Ulrich W. Preuss. Textbook of Addiction Treatment: International Perspectives. 2015; : 261 doi: 10.1007/978-88-470-5322-9_140
|
5 |
Hannes Hagström. Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?. Current Hepatology Reports 2017; 16(2): 152 doi: 10.1007/s11901-017-0343-0
|
6 |
Sigurdur Jon Juliusson, Jon Kristinn Nielsen, Valgerdur Runarsdottir, Ingunn Hansdottir, Ragna Sigurdardottir, Einar S. Björnsson. Lifetime alcohol intake and pattern of alcohol consumption in patients with alcohol-induced pancreatitis in comparison with patients with alcohol use disorder. Scandinavian Journal of Gastroenterology 2018; 53(6): 748 doi: 10.1080/00365521.2018.1455893
|
7 |
Christine C. Hsu, Kris V. Kowdley. The Effects of Alcohol on Other Chronic Liver Diseases. Clinics in Liver Disease 2016; 20(3): 581 doi: 10.1016/j.cld.2016.02.013
|
8 |
Eduardo A. Rodriguez, Elizabeth J. Carey, Keith D. Lindor. Emerging treatments for primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 2017; 11(5): 451 doi: 10.1080/17474124.2017.1293524
|
9 |
Fatima Isa, Grace M. Turner, Geetinder Kaur, Derek Kyte, Anita Slade, Tanya Pankhurst, Larissa Kerecuk, Thomas Keeley, James Ferguson, Melanie Calvert. Patient-reported outcome measures used in patients with primary sclerosing cholangitis: a systematic review. Health and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0951-6
|
10 |
Claudio Pinto, Elisabetta Ninfole, Antonio Benedetti, Luca Maroni, Marco Marzioni. Aging-Related Molecular Pathways in Chronic Cholestatic Conditions. Frontiers in Medicine 2020; 6 doi: 10.3389/fmed.2019.00332
|
11 |
Jennifer L Horsley-Silva, Elizabeth J Carey, Keith D Lindor. Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 2016; 1(1): 68 doi: 10.1016/S2468-1253(16)30010-3
|
12 |
Jon Kristinn Nielsen, Sigurdur Olafsson, Ottar M. Bergmann, Valgerdur Runarsdottir, Ingunn Hansdottir, Ragna Sigurdardottir, Einar S. Björnsson. Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 762 doi: 10.1080/00365521.2017.1295466
|
13 |
Colin Rumbolt, Gerald Y Minuk. The effects of binge drinking on healthy and diseased livers. Canadian Liver Journal 2021; 4(2): 93 doi: 10.3138/canlivj-2020-0037
|
14 |
Andreas Schult, Knut Stokkeland, Bo-Göran Ericzon, Rolf Hultcrantz, Johan Franck, Per Stål, Maria Castedal. Alcohol and drug use prior to liver transplantation: more common than expected in patients with non-alcoholic liver disease. Scandinavian Journal of Gastroenterology 2019; 54(9): 1146 doi: 10.1080/00365521.2019.1656772
|
15 |
Carolin Lackner, Dina Tiniakos. Fibrosis and alcohol-related liver disease. Journal of Hepatology 2019; 70(2): 294 doi: 10.1016/j.jhep.2018.12.003
|